Atherogenic Age: Plaque deposition risk environment
Reduce ApoB particle burden and optimize the retention environment.
Longevity Score
Atherogenic age is the sediment question: how much material is circulating that could be retained in the artery wall, and how likely is that retention? Standard care often compresses this into total cholesterol, but the physics of plaque is driven by particle count, vessel permeability and time — not by one summary number.
Atherosclerosis is not mysterious. It is a long-duration deposition process: particles circulate, the lining becomes permeable or sticky under certain conditions, particles are retained, and over decades retention becomes plaque. The point of measuring is clarity, not fear. Low sediment risk means you can optimise with broad levers; existing plaque means the strategy tightens.
The atherogenic dial is one of eight that make up your Longevity Score, and carries 14% of the composite. It is scored from 5 biomarkers against book-based scoring ranges rather than standard clinical cut-offs. These ranges are not a diagnosis or an individual treatment target.
Calculate your atherogenic age free →Biomarkers scored in this dial
You do not need all of them. Blank values are excluded from scoring, never counted as zero. The markers tagged short-form input appear in the calculator's short form; this is not a recommendation to obtain tests.
How fast each marker actually responds
Markers move on very different timescales, and treating a slow one as a steering signal is the most common way people conclude that nothing is working. Steer with the fast signals; audit with the slow ones.
Practical rule. Do not chase a calcium score month to month. Control ApoB and the conditions that promote retention, and treat Lp(a) as a constraint that raises the urgency of everything else.
How to improve your atherogenic age
Nutrition
- Reduce saturated fat to <6–7% of calories: replace with mono/polyunsaturated fats (olive oil, avocado, nuts)
- Soluble fiber 10–15g/day (psyllium husk, oats, legumes): reduces LDL/ApoB ~5–10% independently
- Replace refined carbohydrates with whole foods: elevated triglycerides from carb excess raise ApoB
- Eliminate trans fats completely (check partially hydrogenated oils in processed foods)
- Add plant sterols/stanols (2g/day via fortified foods or supplements): reduces LDL 10–15%
- Mediterranean dietary pattern: robust evidence for ApoB reduction and CV risk reduction
Training
- Aerobic exercise 150+ min/week: reduces triglycerides significantly (primary atherogenic remnant driver)
- Strength training 3×/week: improves LPL activity (enzyme that clears triglyceride-rich particles)
- Visceral fat reduction (via any consistent energy deficit): most powerful lifestyle lever for ApoB/triglycerides
Supplements
- Omega-3 (EPA+DHA) — 3–4g/day with foodevidence AReduces triglycerides 20–30% at therapeutic doses. FDA-approved (Vascepa) at 4g/day for hypertriglyceridemia.
- Psyllium husk — 10–15g/day in waterevidence AMeta-analysis: consistent LDL/ApoB reduction. Also improves insulin sensitivity.
- Red yeast rice — 1200–2400 mg/dayevidence BContains naturally occurring lovastatin. Clinically significant LDL reduction. Requires physician oversight — same caution as statins.
- Bergamot extract — 500–1000 mg/dayevidence BRCTs show LDL and ApoB reduction via HMG-CoA reductase inhibition and PCSK9 modulation.
- Niacin (B3) — 500–1000 mg/dayevidence BRaises HDL, lowers triglycerides and Lp(a). Use flush-free form carefully; monitor liver enzymes.
Evidence tiers: A = consistent human RCT support, B = mixed or mechanistic, C = early or anecdotal.
Lifestyle
- If Lp(a) is elevated (>125 nmol/L): this is genetic and lifestyle-resistant — focus entirely on ApoB reduction and aspirin discussion with physician
- Address metabolic dysfunction: insulin resistance is a major driver of atherogenic dyslipidemia
- Avoid smoking entirely: accelerates oxidized LDL and plaque progression dramatically
How this dial interacts with the others
No dial moves alone. If progress here has stalled, the cause is often sitting in one of these:
- Vascular age — Endothelial condition determines whether circulating particles are retained at all.
- Inflammatory age — Inflammation increases retention and destabilises existing plaque.
- Metabolic age — Insulin resistance shifts particle profiles in the wrong direction.
Assessment inputs to discuss
These are inputs for the assessment, not tests everyone needs. Discuss with your clinician which, if any, are appropriate and whether existing results can be used.
Standard lipid panels include total cholesterol, HDL cholesterol and triglycerides; LDL cholesterol is often calculated. ApoB is a separate measure of atherogenic particle concentration.
When to retest
Retest ApoB and lipid panel at 8–12 weeks after dietary changes. CAC scan as baseline audit if >40 yrs.
Frequently asked questions
What does the atherogenic dial measure?
Plaque deposition risk environment. Atherogenic age is the sediment question: how much material is circulating that could be retained in the artery wall, and how likely is that retention? Standard care often compresses this into total cholesterol, but the physics of plaque is driven by particle count, vessel permeability and time — not by one summary number.
How much does atherogenic age count toward my Longevity Score?
The atherogenic dial carries 14% of the composite Longevity Score, scored from 5 biomarkers against longevity-optimised ranges rather than standard clinical cut-offs.
What is the practical rule for improving atherogenic age?
Do not chase a calcium score month to month. Control ApoB and the conditions that promote retention, and treat Lp(a) as a constraint that raises the urgency of everything else.
The other seven dials
Get your full Longevity Score →Framework and narrative adapted from 8 Dials of Longevity: An Engineering Framework for Measuring and Extending Healthspan by Steve Fayzulayev & Naomi Fayzulayev, FNP-C, MSN.